US BANCORP \DE\ - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 43 filers reported holding LEAP THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,074
-24.4%
6,1000.0%0.00%
Q4 2022$2,745
-45.1%
6,1000.0%0.00%
Q3 2022$5,000
-28.6%
6,1000.0%0.00%
Q2 2022$7,000
-36.4%
6,1000.0%0.00%
Q1 2022$11,000
-45.0%
6,1000.0%0.00%
Q4 2021$20,000
-16.7%
6,1000.0%0.00%
Q3 2021$24,000
+140.0%
6,1000.0%0.00%
Q2 2021$10,000
-16.7%
6,1000.0%0.00%
Q1 2021$12,000
-14.3%
6,1000.0%0.00%
Q4 2020$14,000
+16.7%
6,1000.0%0.00%
Q3 2020$12,000
-7.7%
6,1000.0%0.00%
Q2 2020$13,000
+30.0%
6,1000.0%0.00%
Q1 2020$10,000
+42.9%
6,1000.0%0.00%
Q4 2019$7,0000.0%6,1000.0%0.00%
Q3 2019$7,000
-36.4%
6,1000.0%0.00%
Q2 2019$11,0000.0%6,1000.0%0.00%
Q1 2019$11,000
-8.3%
6,1000.0%0.00%
Q4 2018$12,000
-75.0%
6,1000.0%0.00%
Q3 2018$48,0006,1000.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders